A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors.
- DOI
- 10.3390/cancers17172924
- Published
- 2025 Sep 6
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers17172924,
title = {A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors.},
author = {Boklan J and Langevin AM and Bielamowicz K and Neville K and Trippett T and Brown V and DuBois SG and Eshun F and Gelfond J and Zomet A and Narendran A and Lacayo NJ},
year = {2025},
journal = {Cancers},
doi = {10.3390/cancers17172924},
url = {https://doi.org/10.3390/cancers17172924}
}RIS
TY - JOUR TI - A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors. AU - Boklan J AU - Langevin AM AU - Bielamowicz K AU - Neville K AU - Trippett T AU - Brown V AU - DuBois SG AU - Eshun F AU - Gelfond J AU - Zomet A AU - Narendran A AU - Lacayo NJ PY - 2025 JO - Cancers DO - 10.3390/cancers17172924 UR - https://doi.org/10.3390/cancers17172924 ER -
APA
J, B., AM, L., K, B., K, N., T, T., V, B., SG, D., F, E., J, G., A, Z., A, N., & NJ, L. (2025). A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors.. Cancers. https://doi.org/10.3390/cancers17172924
Source records
- pubmed · retrieved 2026-09-26T03:24:36.655Z